What are the antibiotics of choice for Group A streptococcal (strep A) infections in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics of Choice for Strep A in Adults

Penicillin remains the first-line treatment for Group A streptococcal infections in adults due to its proven efficacy, safety, narrow spectrum, and low cost. 1

First-Line Treatment Options

  • Oral penicillin V is recommended for adults at 250 mg three to four times daily or 500 mg twice daily for 10 days 1
  • Amoxicillin can be used as an alternative to penicillin V with equal efficacy 1
  • For patients unlikely to complete a full 10-day course of oral therapy, intramuscular benzathine penicillin G (1.2 million units as a single dose) is preferred 1

Treatment for Penicillin-Allergic Patients

  • For non-immediate penicillin allergy, first-generation cephalosporins (such as cephalexin) can be used 2
  • For patients with immediate hypersensitivity to penicillin, erythromycin is a suitable alternative 1
  • Clindamycin (7 mg/kg per dose three times daily, maximum 300 mg per dose, for 10 days) is recommended for patients with severe penicillin allergy 2

Treatment Duration Considerations

  • Most oral antibiotics must be administered for a full 10-day course to achieve maximal pharyngeal eradication of Group A streptococci 1
  • Azithromycin is an exception, requiring only a 5-day course (500 mg on day 1, followed by 250 mg once daily for 4 days) due to its prolonged tissue half-life 1, 3

Special Considerations for Invasive Infections

  • For invasive Group A streptococcal infections (like bacteremia), a combination of intravenous penicillin G plus clindamycin is recommended 4
  • Clindamycin suppresses streptococcal toxin production while penicillin provides bactericidal activity 4, 5

Common Pitfalls and Caveats

  • Sulfonamides and tetracyclines should not be used for treatment of Group A streptococcal pharyngitis due to higher rates of resistance 1
  • Macrolide resistance among Group A streptococci varies geographically, with rates around 5-8% in the United States 2
  • Penicillin alone may be inadequate for severe invasive Group A streptococcal infections due to the "Eagle effect" (large inoculum effect) 4, 5
  • Although some studies suggest that first-generation cephalosporins may have better eradication rates than penicillin, current guidelines still recommend penicillin as first-line therapy due to its long track record of safety and efficacy 6
  • Twice-daily dosing of penicillin V (500 mg) has been shown to be as effective as three-times-daily dosing (250 mg), which may improve adherence 7

Management of Close Contacts and Carriers

  • It is usually not necessary to perform throat cultures for asymptomatic household contacts of patients with Group A streptococcal pharyngitis 1
  • For documented outbreaks in group settings (schools, day care centers), throat cultures should be performed for all patients, but only those with positive cultures should receive antimicrobial treatment 1
  • Clindamycin has demonstrated high efficacy in eradicating streptococci in chronic carriers 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Group A Streptococcal Bacteremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Invasive group A streptococcal infection: New concepts in antibiotic treatment.

International journal of antimicrobial agents, 1994

Research

Diagnosis and treatment of streptococcal pharyngitis.

American family physician, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.